There’s a Reason the Most Important Data on Earth is protected by Fidelis
5
of the 6 US Military Branches Defended
7
of the 10 Largest US Government Agencies Protected
6.7M
Year-to-Date High Severity Malware Threats Identified
16K
Year-to-Date Critical Vulnerability Exploitations Attempts Detected
Protecting the leading enterprises and government agencies worldwide for over 20 years.
-
7 of the 10 largest US government agencies.
-
5 of the 6 branches of the US military
-
#1 largest cellphone manufacturer in the world
-
#1 largest pharmacy chain in the world
-
#1 largest mobile service provider in the US
-
#1 largest defense contractor in the world
-
#1 largest pharmaceutical company in the world
-
#1 largest convenience store chain in the world
Why is Fidelis winning against its competitors?
Our customers detect post-breach attacks over 9x faster.
The Fidelis Challenge.
No one sees what we see and we'll prove it
Run Fidelis Elevate or Halo in your enterprise environment for 30 days. We guarantee we will find threats your current provider has never even seen. If we are wrong, we will pay you $50,000 or donate $50,000 to a children’s charity of your choice.
Products
Discover Our Product
The Fidelis Elevate
Built on a Foundation of AI (Before it was Cool)
Our customers rely on our AI-driven Fidelis Elevate to:
Predict future attacks before they happen
Stop phishing attempts in real-time
Conduct rapid forensic analysis to confidently respond to present threats
The Fidelis Halo™
Built on a Foundation of AI (Before it was Cool)
Our customers rely on our AI-driven Fidelis Halo™ to:
Predict future attacks before they happen
Stop phishing attempts in real-time
Conduct rapid forensic analysis to confidently respond to present threats
No one sees what we see and we'll prove it
Our customers detect post-breach attacks over 9x faster.
Take the Fidelis Challenge:
Run Fidelis in your environment for 30 days. We guarantee we will find threats your current provider has never even seen. If we are wrong, we will write you a check for $25,000 or donate to a charity of your choice.
Integrations
Case Study
Lyell Immunopharma Improves Cloud Security with Fidelis Cybersecurity
Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.
Testimonials
What Our Client Say About Us
Resources
Check Out Our Recent Content
Mastering Active Directory Security
Active Directory (AD) is the gateway to an estimated 90% of networks worldwide, making it a primary attack vector. Reclaim your advantage over your adversary by becoming a master of AD defense.
June 2023 Threat Intelligence Summary
Stay ahead of the threat with our expert analysis of CISA Directives regarding MOVEit vulnerabilities, Russian state-sponsored threat actor movements, the emergence of new ransomware, and more.
Fortifying Your Defenses: A Crawl, Walk, Run Approach to Zero Trust
Watch the replay of this discussion on the power of adopting a crawl, walk, run approach to Zero Trust, and learn how to unleash the true potential of your existing cybersecurity investments.
Threat Geek
Recent Posts
June 2023 Threat Intelligence Summary
Introduction When threats emerge, the Fidelis Cybersecurity Threat Research team (TRT) is ready. Each month, the Threat Intelligence Summary examines
New MOVEit Vulnerability: What to Do NOW to Protect Your Organization
Introduction On May 31, 2023 Progress Software disclosed a SQL injection vulnerability (CVE-2023-34362) in the MOVEit Transfer that could lead to escalated
May 2023 Threat Intelligence Summary
Introduction When threats emerge, the Fidelis Cybersecurity Threat Research team (TRT) is ready. Each month, the Threat Intelligence Summary examines
June 2023 Threat Intelligence Summary
Introduction When threats emerge, the Fidelis Cybersecurity Threat Research team (TRT) is ready. Each month, the Threat Intelligence Summary examines
New MOVEit Vulnerability: What to Do NOW to Protect Your Organization
Introduction On May 31, 2023 Progress Software disclosed a SQL injection vulnerability (CVE-2023-34362) in the MOVEit Transfer that could lead to escalated
May 2023 Threat Intelligence Summary
Introduction When threats emerge, the Fidelis Cybersecurity Threat Research team (TRT) is ready. Each month, the Threat Intelligence Summary examines
May 2023 Threat Intelligence Summary
Introduction When threats emerge, the Fidelis Cybersecurity Threat Research team (TRT) is ready. Each month, the Threat Intelligence Summary examines
New MOVEit Vulnerability: What to Do NOW to Protect Your Organization8
Introduction “Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
New MOVEit Vulnerability: What to Do NOW to Protect Your Organization7
Introduction “Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Blog
Our Recent Blog
June 2023 Threat Intelligence Summary
Introduction When threats emerge, the Fidelis Cybersecurity Threat Research team (TRT) is ready. Each month, the Threat Intelligence Summary examines
May 2023 Threat Intelligence Summary
Introduction When threats emerge, the Fidelis Cybersecurity Threat Research team (TRT) is ready. Each month, the Threat Intelligence Summary examines
New MOVEit Vulnerability: What to Do NOW to Protect Your Organization
Introduction On May 31, 2023 Progress Software disclosed a SQL injection vulnerability (CVE-2023-34362) in the MOVEit Transfer that could lead to escalated
Policy assignments work surprisingly well. I can just set policies for our assets and servers, and those policies apply to any new instances that we spin up.